Which has the lower trailing P/E, ABT or AZN?

AZN has the lower trailing P/E: ABT trades at 33.96 and AZN at 12.77. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABT or AZN?

Over the past five years, AZN grew revenue faster — ABT at a 2.98% CAGR versus AZN at 16.99%.

Does ABT or AZN pay a bigger dividend?

ABT yields 2.31% and AZN yields 1.89% based on trailing dividends and the latest price.

Is ABT or AZN more profitable?

AZN runs the higher net margin — ABT at 11.65% versus AZN at 17.19%.

How have ABT and AZN total returns compared?

Over the past 10 years, ABT delivered 11.02% and AZN delivered 13.02% annualized total return. Past performance doesn't predict future results.

Abbott Laboratories (ABT) vs AstraZeneca PLC (AZN)

A side-by-side comparison of Abbott Laboratories and AstraZeneca PLC across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.

ABT

Abbott Laboratories

$184.11B

$105.70HealthcareDelayed quote: Jul 31, 2026, 4:02 PM EDT

AZN

AstraZeneca PLC

$131.47B

$169.64HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT

Total return — ABT vs AZN

growth of $100 · dividends reinvested · last 30y

ABT +1948.2%AZN +2029.9%AZN compounded faster

ABT AZN

ABT vs AZN: by the numbers

•ABT is the larger company ($184.11B vs $131.47B market cap).
•AZN trades at the lower trailing earnings multiple (12.77 vs 33.96 P/E), one valuation lens rather than an overall verdict.
•AZN converts more revenue to profit (17.19% vs 11.65% net margin).
•AZN grew revenue faster over the past five years (16.99% vs 2.98% CAGR).
•ABT pays the higher dividend yield (2.31% vs 1.89%).

Metrics side by side

Valuation

Metric	ABT	AZN
P/E ratio	33.96	12.77
Forward P/E	19.15	16.55
P/S ratio	3.95	2.19
P/B ratio	3.54	2.80
PEG ratio	4.13	0.29
EV / EBITDA	21.37	7.89
FCF yield	4.00%	6.09%

Profitability

Metric	ABT	AZN
Gross margin	56.80%	81.68%
Operating margin	17.03%	23.69%
Net margin	11.65%	17.19%
ROE	10.42%	21.95%
ROIC	8.43%	13.03%

Dividends

Metric	ABT	AZN
Dividend yield	2.31%	1.89%
Payout ratio	65.24%	24.24%

Growth (annualized)

Metric	ABT	AZN
Revenue CAGR (5Y)	2.98%	16.99%
EPS CAGR (5Y)	8.22%	22.02%
FCF CAGR (5Y)	5.26%	15.68%
Total return CAGR (5Y)	-0.78%	10.60%

Frequently asked

Which has the lower trailing P/E, ABT or AZN?: AZN has the lower trailing P/E: ABT trades at 33.96 and AZN at 12.77. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABT or AZN?: Over the past five years, AZN grew revenue faster — ABT at a 2.98% CAGR versus AZN at 16.99%.
Does ABT or AZN pay a bigger dividend?: ABT yields 2.31% and AZN yields 1.89% based on trailing dividends and the latest price.
Is ABT or AZN more profitable?: AZN runs the higher net margin — ABT at 11.65% versus AZN at 17.19%.
How have ABT and AZN total returns compared?: Over the past 10 years, ABT delivered 11.02% and AZN delivered 13.02% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABT analysis Full AZN analysis Interactive comparison tool

Dig into the metrics

Abbott Laboratories P/E ratio AstraZeneca P/E ratio Abbott Laboratories dividend yield AstraZeneca dividend yield Abbott Laboratories ROE AstraZeneca ROE Abbott Laboratories operating margin AstraZeneca operating margin Abbott Laboratories revenue growth AstraZeneca revenue growth Abbott Laboratories free cash flow AstraZeneca free cash flow

Abbott Laboratories & AstraZeneca appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.